Literature DB >> 25745014

Checkpoint blockade immunotherapy for cancer comes of age.

Vicki Brower.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25745014     DOI: 10.1093/jnci/djv069

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.

Authors:  Gabriele Gamerith; Arno Amann; Bettina Schenk; Thomas Auer; Hans Lentzen; Dirk O Mügge; Katharina M Cima; Judith Löffler-Ragg; Wolfgang Hilbe; Heinz Zwierzina
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

2.  Single-cell profiling of microenvironment components by spatial localization in pancreatic ductal adenocarcinoma.

Authors:  Song Han; Dongtao Fu; Gerik W Tushoski; Lingsong Meng; Kelly M Herremans; Andrea N Riner; Thomas J Geoge; Zhiguang Huo; Steven J Hughes
Journal:  Theranostics       Date:  2022-06-27       Impact factor: 11.600

Review 3.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

Review 4.  Application of PD-1 Blockade in Cancer Immunotherapy.

Authors:  Xiaomo Wu; Zhongkai Gu; Yang Chen; Borui Chen; Wei Chen; Liqiang Weng; Xiaolong Liu
Journal:  Comput Struct Biotechnol J       Date:  2019-05-23       Impact factor: 7.271

5.  Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity.

Authors:  Muyang Yang; Zhongwei Zhang; Jiajia Chen; Mengying Xu; Jiaquan Huang; Ming Wang; Weina Li; Xiaoyang Wan; Man-Fung Yuen; Xiaoping Luo; Dong Xi; Qin Ning
Journal:  J Exp Clin Cancer Res       Date:  2019-08-13

6.  Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer.

Authors:  Hui Chen; Fuqiang Zu; Taofei Zeng; Ziang Chen; Jinhong Wei; Peng Liu; Zeyu Li; Lei Zhou; Huaitao Wang; Hao Tan; Xiaodong Tan
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

Review 7.  CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?

Authors:  Qingan Jia; Qiongzhu Dong; Lunxiu Qin
Journal:  Oncotarget       Date:  2016-01-12

8.  Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer.

Authors:  Bogang Wu; Xiujie Sun; Harshita B Gupta; Bin Yuan; Jingwei Li; Fei Ge; Huai-Chin Chiang; Xiaowen Zhang; Chi Zhang; Deyi Zhang; Jing Yang; Yanfen Hu; Tyler J Curiel; Rong Li
Journal:  Oncoimmunology       Date:  2018-08-23       Impact factor: 8.110

9.  Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.

Authors:  Hong Luan; Chuang Zhang; Tuo Zhang; Ye He; Yanna Su; Liping Zhou
Journal:  Dis Markers       Date:  2020-08-31       Impact factor: 3.434

10.  The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors.

Authors:  Na Liu; Jinmei Mao; Peizhi Tao; Hao Chi; Wenhui Jia; Chunling Dong
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.